Small Molecule innovator CDMO Market (By Product: Small Molecule API, Small Molecule Drug Product; By Stage Type: Preclinical, Clinical, Commercial; By Customer Type: Pharmaceutical, Biotechnology; By Therapeutic Area: Cardiovascular Diseases, Oncology, Respiratory Disorders, Neurology, Metabolic Disorders, Infectious Diseases) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 20222030

The global small molecule innovator CDMO market size was valued at USD 41.1 billion in 2020, and is predicted to be worth around USD 73.9 billion by 2030, registering a CAGR of 6.4% during the forecast period 2022 to 2030.

Growth Factors

The COVID-19 pandemic has significantly impacted market growth. During this crisis, CDMOs are playing an important role in meeting the needs of pharmaceutical companies, biotech companies, and other end users. These have been working diligently towards the development of small-molecule drugs against SARS-CoV-2 since the end of 2019.

COVID-19 has caused a significant impact on the API CDMO market where China was a key performing country in contract manufacturing of APIs. In China, due to a strict government-imposed lockdown, 44 firms became non-operational and several governments chose to boycott APIs manufactured in China. To combat this shortage, several countries have started manufacturing their own APIs. COVID-19 has changed supply chains but has also boosted the API CDMO market. With the growing demand for outsourcing by pharma companies, CDMOs are now focusing more on continuous bioprocessing and process intensification.

There was unprecedented growth in 2020 due to the COVID-19 pandemic. The EFCG reported that around 80% of chemicals used to make drugs sold in Europe are supplied from India and China. The major factors fueling the growth of this market include increasing pharmaceutical R&D investment and the rising incidence of cancer and age-related disorders across the globe. Another factor fueling market growth is the growing demand for small molecule drugs. In 2020, small molecule drugs dominated new molecular entities (NMEs) approvals. 

Report Coverage

By Product Analysis

The small molecule API segment dominated the market and accounted for a revenue share of over 60.0% in 2021. This growth can primarily be attributed to the rising demand for small molecule innovators.

The small molecule drug product segment is expected to expand at a CAGR of 6.0% over the forecast period. The small molecule drug substances have become more complex, with manufacturing methods becoming more specialized. 

By Stage Type Analysis

The clinical segment dominated the market in 2021 and held a revenue share of over 50.0%. The clinical phase represents the organization's future, where mistakes can result in products not making it through the clinic or clinical programs being delayed, not to mention the impact on patients. 

The commercial segment is projected to register the fastest growth rate of 7.2% over the forecast period. Rising demand for outsourcing by small- and medium-sized pharmaceutical companies is one of the factors driving the segment.

The labor paradigm that had previously serviced R&D activities will not work in the commercial space. This is where the role of CDMOs comes into play. CDMOs offer specialized expertise, time-saving, and cost-efficiency, which is likely to propel the segment growth during the forecast period.

By Customer Type Analysis

The pharmaceutical segment accounted for over 90.0% share of the global revenue in 2021. The biotechnology segment includes biotechnology firms. In these firms, the production of small molecules is also done. 

The segment's expansion is being fueled by factors such as rising biopharmaceutical demand and enhanced molecular efficiency. Furthermore, this growth can be attributed to large investments in the biotechnology and biopharmaceutical industries.

By Therapeutic Area Analysis

The oncology segment held the largest revenue share of over 40.0% in 2021 and is anticipated to register the fastest growth rate over the forecast period owing to the increasing number of cancer cases globally.

Increased government reimbursement policies and a rise in financing for the development of small molecule oncology therapies are other factors boosting the segment growth. In 2018, 42 NCEs were approved, and 38 in 2019 - a significant rise over the recent average of 25-35 NCE approvals per year. 

The industry is also being driven by supportive government reimbursement policies and financing towards the development of small molecule oncology therapies. In addition, CDMOs are increasing their investments in facilities for the production of highly powerful APIs (HPAPIs). 

By Regional Analysis

Asia Pacific accounted for the largest revenue share of over 40.0% in 2021. A key factor fueling the regional market growth is the significantly cheaper manufacturing costs than North America and Europe and favorable laws. 

North America held the second-largest revenue share in 2021. It is one of the major contributors to the growth of the global market. It is characterized by the presence of several established pharmaceutical, biotechnology, and medical device companies. 

Key Players

• Piramal Pharma Solutions

• Corden Pharma

• Wuxi AppTec

• Cambrex Corporation

• Recipharm AB

• Thermo Fisher Pantheon

• Lonza Group Ltd.

• Catalent Inc.

• Siegfried Holding AG

• Boehringer Ingelheim

• Covance Inc. 

Market Segmentation

• By Product

  • Small Molecule API

  • Small Molecule Drug Product

    • Oral Solid Dose

    • Semi-Solid Dose

    • Liquid Dose

    • Others

• By Stage Type 

  • Preclinical

  • Clinical

    • Phase I

      • Small

      • Medium

      • Large

    • Phase II

      • Small

      • Medium

      • Large

    • Phase III

      • Small

      • Medium

      • Large

  • Commercial

• By Customer Type 

  • Pharmaceutical

    • Small

    • Medium

    • Large

  • Biotechnology

• By Therapeutic Area 

  • Cardiovascular Diseases

  • Oncology

  • Respiratory Disorders

  • Neurology

  • Metabolic Disorders

  • Infectious Diseases

  • Others

• Regional

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

  • Asia Pacific

    • India

    • Japan

    • China

    • Australia

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

The small molecule innovator CDMO market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

The report provides size (in terms of volume and value) of small molecule innovator CDMO market for the base year 2021 and the forecast between 2022 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

This report focuses on the global small molecule innovator CDMO market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the small molecule innovator CDMO market development in United States, Europe and China.

It is pertinent to consider that in a volatile global economy, we haven’t just conducted small molecule innovator CDMO market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.

In terms of production side, this report researches the small molecule innovator CDMO capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.

In terms of consumption side, this report focuses on the consumption of small molecule innovator CDMO by regions (countries) and application.

Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global small molecule innovator CDMO market. These figures have been provided in terms of both revenue and volume for the period 2019 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.

With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major small molecule innovator CDMO market companies.

Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of small molecule innovator CDMO market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.

The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.

Overall, this is an in-depth research report specifically for the small molecule innovator CDMO industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.

small molecule innovator CDMO market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to small molecule innovator CDMO market.

Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of small molecule innovator CDMO market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.

Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new small molecule innovator CDMO market. These factors have benefited the growth of the global market for small molecule innovator CDMO. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.

New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for small molecule innovator CDMO. The global market is segmented on the basis of region, application, end-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).

In this study, the years considered to estimate the market size of small molecule innovator CDMO are as follows:

• History Year: 2019-2020

• Base Year: 2021

• Forecast Year 2022  to 2030

Reasons to Purchase this Report:

- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

The study objectives of this report are:

• To analyze and study the global market capacity, production, value, consumption, status (2019-2021) and forecast (2022-2030);
• Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
• Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
• To define, describe and forecast the market by type, application and region.
• To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To identify significant trends and factors driving or inhibiting the market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
• To strategically profile the key players and comprehensively analyze their growth strategies.